Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00177567Phase 4Completed
Phase 4, open-label, single-arm trial of lithium carbonate, divalproex sodium, risperidone, olanzapine, paroxetine and 5 more in bipolar disorder (BD), sponsored by University of Pittsburgh. Primary endpoints: Percent of subjects remitting from index affective episode, Time to remission and 1 more. Started Jul 2001; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00177567.